文献速递糖尿病

全球原住民成人2型糖尿病患病率系统综述

Prevalence of type 2 diabetes among global Indigenous adult populations: a systematic review.
PubMed 文献 · Diabetologia · 2025-12-21

该系统综述检索1980年1月1日至2023年3月3日的MEDLINE、Embase和CINAHL英文文献,纳入报告全球18岁及以上原住民成人2型糖尿病患病率或病例数的研究,最终202项研究符合纳入标准,覆盖37个国家的至少187个原住民群体。患病率范围为0至40%,1980至2020年间每个十年平均有73%的原住民群体2型糖尿病患病率高于全球估计水平,患病率随时间与年龄增长而升高,45-54岁组报告患病率最高(50.5%)。

要点

  • 原住民成人2型糖尿病患病率范围为0至40%,1980至2020年每个十年平均73%的群体高于全球估计水平。
  • 患病率随时间与年龄增加而升高,45-54岁年龄组报告患病率最高,为50.5%。
  • 73%的研究报告原住民女性2型糖尿病患病率高于原住民男性。

核心结论

  • 全球原住民成人2型糖尿病患病率在1980至2020年每个十年均明显高于全球平均水平,平均73%的群体报告更高患病率。
  • 这些发现强调许多原住民社区数十年来承受持续且不成比例的糖尿病负担。

研究设计与样本

  • 系统综述,检索MEDLINE、Embase和CINAHL于1980年1月1日至2023年3月3日发表的英文研究。
  • 纳入报告全球18岁及以上原住民成人2型糖尿病患病率和/或病例数的研究,共202项符合纳入标准。
  • 纳入研究覆盖37个国家的至少187个原住民群体;采用改良Newcastle-Ottawa质量评估量表(含原住民特定标准)评估文献质量。

主要发现

  • 2型糖尿病患病率范围为0至40%。
  • 1980至2020年间每个十年平均73%的原住民群体2型糖尿病患病率高于全球估计水平。
  • 许多群体患病率随时间与年龄增长而升高,45-54岁年龄组报告患病率最高(50.5%)。
  • 73%的研究报告原住民女性患病率高于原住民男性。

关键数值与推荐

  • 患病率范围0至40%,45-54岁年龄组最高报告患病率为50.5%。
  • 1980至2020年每个十年平均73%的原住民群体患病率高于全球估计值;73%的研究显示女性高于男性。

临床怎么用

  • 提示临床应关注原住民成人2型糖尿病的高负担,尤其45-54岁人群与原住民女性。
  • 支持开展由原住民主导、文化安全且针对特定原住民群体的预防与管理实践,以促进公平结局。

局限性

  • 存在发表偏倚,可能导致纳入本综述的研究偏少。
  • 部分研究未命名具体民族/部落/群体,原住民群体数量为近似值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Despite evidence documenting high prevalence of type 2 diabetes among several Indigenous populations, a comprehensive systematic review of type 2 diabetes among global Indigenous Peoples has not been recently conducted. Our aim was to report region-, time-, age- and sex-specific type 2 diabetes prevalence among Indigenous adult populations globally. METHODS: MEDLINE, Embase and CINAHL were searched for English-language studies published between 1 January 1980 and 3 March 2023. Studies reporting type 2 diabetes prevalence and/or cases of diabetes among global Indigenous adult populations aged 18 years and older were included. Type 2 diabetes prevalence data were extracted for the overall Indigenous population, sex, age group and year. Summaries of extracted data were tabulated, and are presented using comprehensive tables and figures. A modified Newcastle-Ottawa quality assessment scale reflective of Indigenous-specific criteria was applied to assess paper quality. RESULTS: The search identified 2332 studies, of which 202 met the inclusion criteria. The included studies represented at least 187 Indigenous populations from 37 countries, although the exact number of populations is approximate, as some studies did not name specific Nations/Tribes/Groups for populations from different geographic regions. Diabetes prevalence ranged from 0 to 40%, with a mean of 73% of Indigenous populations reporting type 2 diabetes prevalence above the estimated global prevalences for every decade between 1980 and 2020. Prevalence increased over time and with age for many populations, with the highest reported prevalence (50.5%) in the 45-54 year age group. Type 2 diabetes prevalence was notably high among Indigenous women, with 73% of studies reporting higher prevalence for Indigenous women than for Indigenous men. Potential limitations include publication bias, which may have led to fewer studies being included in this review. CONCLUSIONS/INTERPRETATION: Type 2 diabetes prevalence among Indigenous adult populations was markedly higher than the global averages in every decade from 1980 to 2020, with a mean of 73% of populations reporting higher prevalence. These findings underscore the persistent and disproportionate burden of diabetes experienced by many Indigenous communities over several decades. Future work should aim to generate representative data on type 2 diabetes prevalence across global Indigenous populations, investigate factors that contribute to alarmingly high and notably low diabetes prevalence, and support Indigenous-led, culturally safe, Indigenous population-specific health practices to prevent and manage type 2 diabetes and achieve equitable outcomes. FUNDING: There was no funding source for this study. TRIAL REGISTRATION: PROSPERO registration no. CRD42021258623.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Claussen C, Papadimos E, Magliano DJ, et al. Prevalence of type 2 diabetes among global Indigenous adult populations: a systematic review. Diabetologia. 2025. PMID: 41422461. doi:10.1007/s00125-025-06624-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。